Neil Mehta, MD

Education
M.D., 2006 - Medicine, University of California, San Francisco
Publications

  1. Zhou K, Albertian R, Wong C, Kuo LS, Thompson LK, Dodge JL, Mehta N, Terrault NA, Cockburn MG. Longer Travel and Traffic are Associated with Adult Liver Transplant Waitlist Mortality in the United States. American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2025. PMID: 39971133


  2. Singal AG, Reddy KR, Colombo M, Morris HL, Mospan AR, Cabrera R, Kelley RK, Kilpatrick RD, Trevisani F, Farinati F, Giannini EG, Mehta N, Fried MW, Sangro B, DAA-PASS and ITA.LI.CA Investigators. DAA-PASS: A Prospective Evaluation of HCC Recurrence After Direct Acting Antiviral Therapy. Journal of viral hepatitis 2025. PMID: 39822115


  3. Jutras G, Mehta N, Lai JC. Differential aging trends among Liver Transplant candidates with and without hepatocellular carcinoma. Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 2025. PMID: 39819830


  4. Xu E, Tabrizian P, Gutierrez J, Hoteit M, Ghaziani T, Zhou K, Parikh N, Ajmera V, Aby E, Shui A, Marino R, Martin A, Wong C, Kao K, Dave S, Florman S, Yao F, Mehta N. Downstaging of hepatocellular carcinoma before liver transplantation: Results from a national multi-center prospective cohort study. Hepatology (Baltimore, Md.) 2025. PMID: 39808828


  5. Mignote Yilma, Kali Zhou, Allison Kwong, Steven Wisel, Monica Tincopa, Jasleen Singh, Justin Steggerda, Alexander Kuo, Veeral Ajmera, Hirsh Trivedi, Aarshi Vipani, Irine Vodkin, Hillary Braun, Neil Mehta, Chris Friese, Peter Stock, Ryutaro Hirose. The California Liver Network: Foreign Born Patients and their progression through liver transplant evaluation. American Journal of Transplantation 2025. PMID:


  6. Hwang SY, Danpanichkul P, Agopian V, Mehta N, Parikh ND, Abou-Alfa GK, Singal AG, Yang JD. Hepatocellular carcinoma: updates on epidemiology, surveillance, diagnosis and treatment. Clinical and molecular hepatology 2024. PMID: 39722614


  7. Singal AG, Quirk L, Boike J, Chernyak V, Feng Z, Giamarqo G, Kanwal F, Ioannou GN, Manes S, Marrero JA, Mehta N, Pillai A, Shaheen NJ, Shaukat A, Sirlin CB, Verna E, Wani S, Wilson Woods A, Yang JD, Parikh ND. Value of HCC surveillance in a landscape of emerging surveillance options: Perspectives of a multi-stakeholder modified delphi panel. Hepatology (Baltimore, Md.) 2024. PMID: 39699563


  8. Norman JS, Li PJ, Kotwani P, Yao FY, Pham S, Gamez J, Mehta N. Enhancing the prognostic accuracy of the RETREAT score with AFP-L3 and DCP tumor markers. Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 2024. PMID: 39661334


  9. Norman J, Mehta N, Kim WR, Liang JW, Biggins SW, Asrani SK, Heimbach J, Charu V, Kwong AJ. Multi-HCC: A practical model to prioritize patients with hepatocellular carcinoma on the liver transplant waiting list. Gastroenterology 2024. PMID: 39622302


  10. Zhou K, Nguyen L, Tabrizian P, Mehta N. Sociodemographic disparities in downstaging to liver transplant for hepatocellular carcinoma. Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 2024. PMID: 39508738


  11. Salem R, Kwong AJ, Kim N, Sze DY, Mehta N. YTTRIUM-90 RADIOEMBOLIZATION HAS BECOME THE MOST UTILIZED BRIDGING TREATMENT FOR LIVER TRANSPLANT CANDIDATES IN THE UNITED STATES. Journal of vascular and interventional radiology : JVIR 2024. PMID: 39522866


  12. Tabrizian P, Marino R, Bhoori S, Zeitlhoefler M, Mehta N, Banz V, Gruttadauria S, Iavarone M, Mazzarelli C, Simonotti N, Yao F, Mazzaferro V, Llovet JM. Neoadjuvant atezolizumab plus bevacizumab prior liver transplantation for hepatocellular carcinoma. JHEP reports : innovation in hepatology 2024. PMID: 39911942


  13. Singal AG, Kilgore KM, Shvets E, Parikh ND, Mehta N, Burak Ozbay A, Teigland C, Hafez O, Schroeder A, Yang A, Schinkel J. Impact of social determinants of health on hepatocellular carcinoma surveillance, treatment, and health care costs. Hepatology communications 2024. PMID: 39392769


  14. Li Z, Chen IC, Centonze L, Magyar CTJ, Choi WJ, Shah S, O'Kane G, Vogel A, De Carlis L, Lerut J, Lai Q, Mehta N, Chen CL, Sapisochin G. Analysis of treatment benefits and prognostic factors for Post-Transplant hepatocellular carcinoma recurrence in a large Euro-American-Asian cohort. Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 2024. PMID: 39356515


  15. Tabrizian P, Holzner M, Ajmera V, Kim AK, Zhou K, Schnickel GT, Torosian K, Hoteit M, Marino R, Li M, Yao F, Florman SS, Schwartz ME, Mehta N. Intention-to-treat outcomes of patients with hepatocellular carcinoma receiving immunotherapy before liver transplant: the multicenter VITALITY study. Journal of hepatology 2024. PMID: 39255928


  16. Yilma M, Houhong Xu R, Saxena V, Muzzin M, Tucker LY, Lee J, Mehta N, Mukhtar N. Survival Outcomes Among Patients With Hepatocellular Carcinoma in a Large Integrated US Health System. JAMA network open 2024. PMID: 39316399


  17. Li PJ, Shah S, Mehta N. Recent Advances in Liver Transplantation for Hepatocellular Carcinoma. Current treatment options in oncology 2024. PMID: 39085572


  18. Parikh ND, Jones P, Salgia R, Bhan I, Grinspan LT, Jou JH, Zhou K, Jalal P, Roccaro G, Rangnekar AS, Benhammou JN, Pillai A, Mehta N, Wedd J, Yang JD, Kim AK, Duarte-Rojo A, Oloruntoba OO, Tevar A, Au JS, Blain Y, Rao S, Catalano OA, Lewis S, Mendiratta-Lala M, King K, Sachdev L, Lee EW, Bruno J, Kamel I, Tolosa C, Kao K, Badawi T, Przybyszewski EM, Quirk L, Nathani P, Haydel B, Leven E, Wong N, Albertian R, Chen A, Aloor FZ, Mohamed IB, Elkheshen A, Marvil C, Issac G, Clinton JW, Woo SM, Yum J, Rieger E, Hutchison AL, Turner DA, Alsudaney M, Hernandez P, Xu Z, Khalid A, Barrick B, Wang B, Tapper EB, Hao W, Singal AG. Development and Validation of a Noninvasive Model for the Detection of High-Risk Varices in Patients with Unresectable HCC. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2024. PMID: 39089513


  19. Rezaee-Zavareh MS, Yeo YH, Wang T, Guo Z, Tabrizian P, Ward SC, Barakat F, Hassanein TI, Shravan D, Veeral A, Bhoori S, Mazzaferro V, Chascsa DMH, Liu MC, Aby ES, Lake JR, Sogbe M, Sangro B, Abdelrahim M, Esmail A, Schmiderer A, Chouik Y, Rudolph M, Sohal D, Giudicelli H, Allaire M, Akce M, Guadagno J, Tow CY, Massoumi H, De Simone P, Kang E, Gartrell RD, Martinez M, Paz-Fumagalli R, Toskich BB, Tran NH, Solino GA, Poltronieri Pacheco DM, Kalman RS, Agopian VG, Mehta N, Parikh ND, Singal AG, Yang JD. Impact of pre-transplant immune checkpoint inhibitor use on post-transplant outcomes in HCC: A systematic review and individual patient data meta-analysis. Journal of hepatology 2024. PMID: 38996924


  20. Zhou K, Lit A, Kuo LS, Thompson LK, Dodge JL, Mehta N, Terrault NA, Ha NB, Cockburn MG. Neighborhood-level Social Determinants of Health and Waitlist Mortality for Liver Transplantation: The Liver Outcomes and Equity Index. Transplantation 2023. PMID: 38049937


  21. Liang J, Li PY, Norman J, Lauzon M, Yeo YH, Trivedi H, Ayoub WS, Kuo A, Friedman ML, Sankar K, Gong J, Osipov A, Hendifar A, Todo T, Kim I, Voidonikolas G, Brennan TV, Wisel SA, Steggarda J, Kosari K, Saouaf R, Nissen N, Yao F, Mehta N, Yang JD. Development and validation of a biomarker index for HCC treatment response. Hepatology communications 2024. PMID: 38896084


  22. Zhou K, Shah S, Thompson LK, Mehta N. Bridging the rural-urban gap in access to liver transplantation. Clinical liver disease 2024. PMID: 38872770


  23. Li M, Bhoori S, Mehta N, Mazzaferro V. Immunotherapy for hepatocellular carcinoma: the next evolution in expanding access to liver transplantation. Journal of hepatology 2024. PMID: 38848767


  24. Zhihao Li, Itsuko Chih-Yi Chen, Grainne O'Kane, Arndt Vogel, Luciano De Carlis, Leonardo Centonze, Quirino Lai, Neil Mehta, Chao-Long Chen, Gonzalo Sapisochin. THU-470-YI Analysis of treatment benefits and prognostic factors for posttransplant hepatocellular carcinoma recurrence in a large Euro-American-Asian cohort. Journal of hepatology 2024. PMID:


  25. Al-Hasan M, Mehta N, Yang JD, Singal AG. Role of biomarkers in the diagnosis and management of HCC. Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 2024. PMID: 38738964


  26. Joshua S. Norman, Neil Mehta, Vivek Charu, Jane Liang, Allison J. Kwong. 163 A PRACTICAL POINTS-BASED MODEL TO PRIORITIZE LIVER TRANSPLANT CANDIDATES WITH HEPATOCELLULAR CARCINOMA IN THE MODERN ERA. Gastroenterology 2024. PMID:


  27. Hundt M, Chen A, Donovan J, Kim N, Yilma M, Tana M, Mehta N, Zhou K. Barriers to liver transplant referral in safety net settings: A national provider survey. Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 2024. PMID: 38687168


  28. Xiaoran Li, Steven Lam, Belia O. Roybal, Sreepriya Balasubramanian, Varun Saxena, Monica Muzzin, Richie Houhong Xu, Farhad Ferzanegan, Robert Freed, Neil Mehta, Mignote Yilma, Jeffrey K. Lee, Brock A. Macdonald, Krisna P. Chai, Suk I. Seo, Nizar A. Mukhtar. EP74 COMPARATIVE ANALYSIS OF RESPONSE RATE AND TIME TO PROGRESSION AMONG NON-TRANSPLANT TREATMENT OPTIONS FOR EARLY- TO INTERMEDIATE-STAGE HEPATOCELLULAR CARCINOMA ACROSS A LARGE, INTEGRATED HEALTHCARE SYSTEM IN NORTHERN CALIFORNIA. Gastroenterology 2024. PMID:


  29. Steven Lam, Xiaoran Li, Belia O. Roybal, Nizar A. Mukhtar, Sreepriya Balasubramanian, Varun Saxena, Monica Muzzin, Richie Houhong Xu, Farhad Ferzanegan, Robert Freed, Neil Mehta, Mignote Yilma, Jeffrey K. Lee, Brock A. Macdonald, Krisna P. Chai, Suk I. Seo. Tu1568 COMPARATIVE ANALYSIS OF THE SAFETY OF NON-TRANSPLANT TREATMENT OPTIONS FOR EARLY- TO INTERMEDIATE-STAGE HEPATOCELLULAR CARCINOMA ACROSS A LARGE, INTEGRATED HEALTH CARE SYSTEM IN NORTHERN CALIFORNIA. Gastroenterology 2024. PMID:


  31. X. Wu, P. Vakil, M. Heller, E. Lehrman, N. Fidelman, N. Mehta, R. Lokken. Abstract No. 158 Cost-Effectiveness Analysis of Resection, Ablation, and Radiation Segmentectomy for Solitary Hepatocellular Carcinoma = 3 cm with Curative Intent. Journal of Vascular and Interventional Radiology 2024. PMID:


  32. Martin SP, Mehta N, Emamaullee J. Immune checkpoint inhibitors in liver transplantation: Current practice, challenges and opportunities. Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 2024. PMID: 38345379


  35. Hassan OT, Behr SC, Ohliger MA, Fowler KJ, Gill RM, Fidelman N, Mehta N, Choi HH. Per-patient Negative Predictive Value of the CT and MRI Liver Imaging Reporting and Data System Version 2018 Treatment Response Algorithm for Hepatocellular Carcinoma. Radiology 2023. PMID: 38112541


  36. Wang M, Cedars MI, Mehta N, Sarkar M. How I Approach Hepatocellular Adenomas in Hormonally Distinct Populations: Time to Think Outside the (Contraceptive Pill) Box. The American journal of gastroenterology 2023. PMID: 37552072


  37. Norman JS, Li PJ, Kotwani P, Shui AM, Yao F, Mehta N. AFP-L3 and DCP Strongly Predict Early Hepatocellular Carcinoma Recurrence After Liver Transplantation. Journal of hepatology 2023. PMID: 37683735


  38. Wu X, Kwong A, Heller M, Lokken RP, Fidelman N, Mehta N. Cost-effectiveness analysis of interventional liver-directed therapies for downstaging of hepatocellular carcinoma before liver transplant. Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 2023. PMID: 37639286


  39. Yilma M, Mehta N. Optimal Liver Transplantation Criteria for Hepatocellular Carcinoma. Surgical oncology clinics of North America 2023. PMID: 37945139


  40. Natarajan B, Tabrizian P, Hoteit M, Frenette C, Parikh N, Ghaziani T, Dhanasekaran R, Guy J, Shui A, Florman S, Yao FY, Mehta N. Downstaging hepatocellular carcinoma before liver transplantation: A multicenter analysis of the "all-comers" protocol in the Multicenter Evaluation of Reduction in Tumor Size before Liver Transplantation (MERITS-LT) consortium. American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2023. PMID: 37532179


  41. Ivanics T, Claasen MP, Samstein B, Emond JC, Fox AN, Pomfret E, Pomposelli J, Tabrizian P, Florman SS, Mehta N, Roberts JP, Emamaullee JA, Genyk Y, Hernandez-Alejandro R, Tomiyama K, Sasaki K, Quintini C, Nagai S, Abouljoud M, Olthoff KM, Hoteit MA, Heimbach J, Taner T, Liapakis AH, Mulligan DC, Sapisochin G, Halazun KJ. Living Donor Liver Transplantation (LDLT) for Hepatocellular Carcinoma (HCC) within and Outside Traditional Selection Criteria: A Multicentric North American Experience. Annals of surgery 2023. PMID: 37522174


  42. Yilma M, Cogan R, Shui AM, Neuhaus JM, Light C, Braun H, Mehta N, Hirose R. Community-level social vulnerability and individual socioeconomic status on liver transplant referral outcome. Hepatology communications 2023. PMID: 37378636


  43. Norman J, Mehta N, Kwong A. Optimizing liver transplant prioritization for hepatocellular carcinoma through risk stratification. Current opinion in organ transplantation 2023. PMID: 37339511


  44. Yilma M, Kim NJ, Shui AM, Tana M, Landis C, Chen A, Bangaru S, Mehta N, Zhou K. Factors Associated With Liver Transplant Referral Among Patients With Cirrhosis at Multiple Safety-Net Hospitals. JAMA network open 2023. PMID: 37289453


  45. Yilma M, Dalal N, Wadhwani SI, Hirose R, Mehta N. Geographic disparities in access to liver transplantation. Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 2023. PMID: 37232214


  46. Singal AG, Llovet JM, Yarchoan M, Mehta N, Heimbach JK, Dawson LA, Jou JH, Kulik LM, Agopian VG, Marrero JA, Mendiratta-Lala M, Brown DB, Rilling WS, Goyal L, Wei AC, Taddei TH. AASLD practice guidance on prevention, diagnosis, and treatment of hepatocellular carcinoma. Hepatology (Baltimore, Md.) 2023. PMID: 37199193


  48. Amit G. Singal, Karl M. Kilgore, Elizabet Shvets, Neehar D. Parikh, Neil Mehta, Ahmet B. Ozbay, Christie Teigland, Omar Hafez, Amy L. Schroeder, Audrey Yang, Jill K. Schinkel. 730 IMPACT OF SURVEILLANCE AND SOCIAL DETERMINANTS OF HEALTH ON TREATMENT RECEIPT AND HEALTHCARE COSTS IN PATIENTS WITH HCC. Gastroenterology 2023. PMID:


  49. Jeff Liang, Po-Yi Li, Joshua S. Norman, Yee Hui Yeo, Hirsh D. Trivedi, Walid S. Ayoub, Alexander Kuo, Marc L. Friedman, Tsuyoshi Todo, Irene Kim, Georgios Voidonikolas, Todd Brennan, Steven Wisel, Kambiz Kosari, Rola Saouaf, Nicholas N. Nissen, Neil Mehta, Ju Dong Yang. Tu1550 UTILITY OF A BIOMARKER-DERIVED SCORE FOR TREATMENT RESPONSE ASSESSMENT IN PATIENTS WITH HEPATOCELLULAR CARCINOMA. Gastroenterology 2023. PMID:


  50. Mehta N, Kotwani P, Norman J, Shui A, Li PY, Saxena V, Chan W, Yao FY. AFP-L3 and DCP are superior to AFP in predicting waitlist dropout in HCC patients: Results of a prospective study. Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 2023. PMID: 37159217


  51. Wu X, Lokken RP, Mehta N. Optimal treatment for small HCC (<3 cm): Resection, liver transplantation, or locoregional therapy? JHEP reports : innovation in hepatology 2023. PMID: 37456674


  52. Hoffman D, Shui A, Gill R, Syed S, Mehta N. Resected Tumor Outcome and Recurrence (RESTORE) Index for Hepatocellular Carcinoma Recurrence after Resection. Cancers 2023. PMID: 37173900


  53. Rice BA, Mehta N, Grab J, Dodge JL, Sherman CB. Patient survey augments detection of harmful alcohol relapse after liver transplant for alcohol-associated cirrhosis. Hepatology communications 2023. PMID: 37058119


  54. X. Wu, A. Kwong, M. Heller, R. Lokken, N. Fidelman, N. Mehta. Abstract No. 251 ? FEATURED ABSTRACT Cost-Effectiveness Analysis of Interventional Liver-Directed Therapies for Downstaging of Hepatocellular Carcinoma Before Liver Transplant. Journal of Vascular and Interventional Radiology 2023. PMID:


  55. Singal AG, Ghaziani TT, Mehta N, Zhou K, Grinspan LT, Benhammou JN, Moon AM, Yang JD, Salgia R, Pillai A, Zheng E, Rich NE, Gopal P, Jalal P, Verna E, Yekkaluri S, Phen S, Melendez-Torres J, Alshuwaykh O, Choi H, Junus K, Grady J, Song M, Leven EA, Yum J, Gowda V, Alsudaney M, Hernandez P, Desai N, Parikh ND. Recall patterns and risk of primary liver cancer for subcentimeter ultrasound liver observations: a multicenter study. Hepatology communications 2023. PMID: 36881615


  56. Wu X, Heller M, Kwong A, Fidelman N, Mehta N. Cost-Effectiveness Analysis of Interventional Liver-Directed Therapies for a Single, Small Hepatocellular Carcinoma in Liver Transplant Candidates. Journal of vascular and interventional radiology : JVIR 2023. PMID: 36804296


  57. Ivanics T, Claasen MPAW, Patel MS, Giorgakis E, Khorsandi SE, Srinivasan P, Prachalias A, Menon K, Jassem W, Cortes M, Sayed BA, Mathur AK, Walker K, Taylor R, Heaton N, Mehta N, Segev DL, Massie AB, van der Meulen JHP, Sapisochin G, Wallace D. Outcomes after liver transplantation using deceased after circulatory death donors: a comparison of outcomes in the UK and the US. Liver international : official journal of the International Association for the Study of the Liver 2023. PMID: 36737866


  58. Brown AE, Shui AM, Adelmann D, Mehta N, Roll GR, Hirose R, Syed SM. Number of Local Regional Therapies for Hepatocellular Carcinoma and Peri-Operative Outcomes after Liver Transplantation. Cancers 2023. PMID: 36765576


  59. Giard JM, Dodge JL, Yao FY, Mehta N. AFP Slope >7.5 ng/ml over 3 Months Before Liver Transplantation for HCC Predicts Recurrence Even After Controlling for AFP at Liver Transplantation. Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 2022. PMID: 35809249


  60. Qureshy Z, Lokken RP, Kakar S, Grab J, Mehta N, Sarkar M. Influence of progestin-only hormonal use on hepatocellular adenomas: A retrospective cohort study. Contraception 2022. PMID: 36476331


  61. Wong RJ, Jayasekera C, Jones P, Kanwal F, Singal AG, Ahmed A, Taglienti R, Younossi Z, Kulik L, Mehta N. An Open-Access, Interactive Decision-Support Tool to Facilitate Guideline-Driven Care for Hepatocellular Carcinoma. Gastroenterology research 2022. PMID: 36660470


  62. Wang M, Sarkar M, Mehta N. Now you see it, now you don't: Estrogen exposure and obesity effects on HCA development and regression. Hepatology (Baltimore, Md.) 2022. PMID: 36176041


  63. Ivanics T, Wallace D, Claasen MPAW, Patel MS, Brahmbhatt R, Shwaartz C, Prachalias A, Srinivasan P, Jassem W, Heaton N, Cattral MS, Selzner N, Ghanekar A, Morgenshtern G, Mehta N, Massie AB, van der Meulen J, Segev DL, Sapisochin G. Low utilization of adult-to-adult LDLT in Western countries despite excellent outcomes: International multicenter analysis of the US, the UK, and Canada. Journal of hepatology 2022. PMID: 36170900


  64. Tabrizian P, Holzner ML, Mehta N, Halazun K, Agopian VG, Yao F, Busuttil RW, Roberts J, Emond JC, Samstein B, Brown RS, Najjar M, Chapman WC, Doyle MM, Florman SS, Schwartz ME, Llovet JM. Ten-Year Outcomes of Liver Transplant and Downstaging for Hepatocellular Carcinoma. JAMA surgery 2022. PMID: 35857294


  65. Huang AC, Dodge JL, Yao FY, Mehta N. National Experience on Waitlist Outcomes for Down-Staging of Hepatocellular Carcinoma: High Dropout Rate in All-Comers. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2022. PMID: 36038129


  66. Kwong AJ, Mehta N. Liver allocation policies for hepatocellular carcinoma have leveled the playing field-But who should be playing? Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 2022. PMID: 35959967


  67. Bernards S, Lee E, Leung N, Akan M, Gan K, Zhao H, Sarkar M, Tayur S, Mehta N. Awarding additional MELD points to the shortest waitlist candidates improves sex disparity in access to liver transplant in the United States. American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2022. PMID: 35871752


  68. Parikh ND, Mehta N, Hoteit MA, Yang JD, John BV, Moon AM, Salgia RJ, Pillai A, Kassab I, Saeed N, Thyssen E, Nathani P, McKinney J, Chan W, Durkin C, Connor M, Alsudaney M, Konjeti R, Durand B, Nissen NN, Kim HP, Paknikar R, Rich NE, Schipper MJ, Singal AG. Association between sustained virological response and clinical outcomes in patients with hepatitis C infection and hepatocellular carcinoma. Cancer 2022. PMID: 35796530


  70. Chen AK, Lunow-Luke T, Yamaguchi S, Praglin C, Agudelo E, Mehta N, Dirks R, Braun HJ, Gardner JM, Roberts JP, Syed SM, Roll GR. Nodular Regenerative Hyperplasia After Liver Transplant; It's All in the Presentation. . 2022. PMID: 35656084


  71. Varun Saxena, Liyan Liu, Joanna B. Ready, Mai Sedki, Krisna P. Chai, Suk I. Seo, Nizar A. Mukhtar, Sreepriya Balasubramanian, Brock A. Macdonald, Neil Mehta, Julie A. Schmittdiel. 531: DEVELOPMENT AND VALIDATION OF A RISK SCORE FOR PREDICTING HEPATOCELLULAR CARCINOMA IN CHRONIC HEPATITIS B WITHIN A LARGE, REPRESENTATIVE, NORTHERN CALIFORNIA COHORT. Gastroenterology 2022. PMID:


  72. Mignote Yilma, Jackson Voelkel, Richie Houhong Xu, Leu-Yen Tucker, Monica Muzzin, Varun Saxena, Neil Mehta, Jeffrey K. Lee, Suk I. Seo, Brock A. Macdonald, Joanna B. Ready, Sreepriya Balasubramanian, Nizar A. Mukhtar. EP1003: EVALUATION OF SOCIOECONOMIC STATUS WITHIN HOTSPOTS OF HEPATOCELLULAR CARCINOMA AMONG A LARGE DIVERSE PATIENT COHORT IN NORTHERN CALIFORNIA. Gastroenterology 2022. PMID:


  73. Silverstein J, Yao FY, Grab JD, Braun HJ, Roberts J, Dodge JL, Mehta N. National Experience with Living Donor Liver Transplantation (LDLT) for Hepatocellular Carcinoma (HCC). . 2022. PMID: 35226793


  74. Kwong A, Hameed B, Syed S, Ho R, Mard H, Arshad S, Ho I, Suleman T, Yao F, Mehta N. Machine learning to predict waitlist dropout among liver transplant candidates with hepatocellular carcinoma. . 2022. PMID: 35029055


  77. Asrani SK, Ghabril MS, Kuo A, Merriman RB, Morgan T, Parikh ND, Ovchinsky N, Kanwal F, Volk ML, Ho C, Serper M, Mehta S, Agopian V, Cabrera R, Chernyak V, El-Serag HB, Heimbach J, Ioannou GN, Kaplan D, Marrero J, Mehta N, Singal A, Salem R, Taddei T, Walling A, Tapper EB. Quality measures in HCC care by the Practice Metrics Committee of the American Association for the Study of Liver Diseases. . 2021. PMID: 34778999


  78. Wallace D, Cowling TE, Suddle A, Gimson A, Rowe I, Callaghan C, Sapisochin G, Ivanics T, Claasen M, Mehta N, Heaton N, van der Meulen J, Walker K. National time trends in mortality and graft survival following liver transplantation from circulatory death or brainstem death donors. . 2021. PMID: 34738095


  81. Ivanics T, Wallace D, Abreu P, Claasen MP, Callaghan C, Cowling T, Walker K, Heaton N, Mehta N, Sapisochin G, van der Meulen J. Survival After Liver Transplantation: An International Comparison Between the United States and the United Kingdom in the Years 2008-2016. . 2021. PMID: 34753895


  82. Cullaro G, Rubin J, Mehta N, Yao F, Verna EC, Lai JC. Sex-Based Disparities in Hepatocellular Carcinoma Recurrence After Liver Transplantation. Transplantation 2020. PMID: 33323764


  83. Mehta N, Yao FY. Liver Transplantation after Down-staging of Hepatocellular Carcinoma with Portal Vein Tumor Thrombus using Y-90 Radioembolization: Pipe Dream or Reality? Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 2021. PMID: 34529890


  84. Reddy SHS, Mehta N, Dodge JL, Hakeem AR, Khorsandi SE, Jassem W, Vilca-Melendez H, Cortes-Cerisuelo M, Srinivasan P, Prachalias A, Heneghan MA, Aluvihare V, Suddle A, Miquel R, Rela M, Heaton ND, Menon KV. Liver transplantation for HCC: validation of prognostic power of the RETREAT score for recurrence in a UK cohort. . 2021. PMID: 34702624


  85. Kwong AJ, Ghaziani TT, Yao F, Sze D, Mannalithara A, Mehta N. National Trends and Waitlist Outcomes of Locoregional Therapy Among Liver Transplant Candidates With Hepatocellular Carcinoma in the United States. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2021. PMID: 34358718


  86. Mehta N, Frenette C, Tabrizian P, Hoteit M, Guy J, Parikh N, Ghaziani TT, Dhanasekaran R, Dodge JL, Natarajan B, Holzner ML, Frankul L, Chan W, Fobar A, Florman S, Yao FY. Down-staging Outcomes for Hepatocellular Carcinoma: Results from the Multicenter Evaluation of Reduction in Tumor Size before Liver Transplantation (MERITS-LT) Consortium. Gastroenterology 2021. PMID: 34331914


  88. Halazun KJ, Rosenblatt RE, Mehta N, Lai Q, Hajifathalian K, Gorgen A, Brar G, Sasaki K, Doyle MBM, Tabrizian P, Agopian VG, Najjar M, Ivanics T, Samstein B, Brown RS, Emond JC, Yao F, Lerut J, Rossi M, Mennini G, Iesari S, Finkenstedt A, Schaefer B, Mittler J, Hoppe-Lotichius M, Quintini C, Aucejo F, Chapman W, Sapisochin G. Dynamic a-Fetoprotein Response and Outcomes After Liver Transplant for Hepatocellular Carcinoma. JAMA surgery 2021. PMID: 33950167


  89. . Neutrophil-to-Lymphocyte ratio predicts high risk explant features and waitlist survival but is not independently associated with recurrence or survival following liver transplantation for hepatocellular carcinoma. Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 2021. PMID: 33570786


  90. Neehar D. Parikh, Neil Mehta, Maarouf Hoteit, Ju Dong Yang, Binu V. John, Andrew M. Moon, Reena Salgia, Anjana A. Pillai, Ihab Kassab, Naba Saeed, Emil Thyssen, Piyush Nithani, Jeffrey Mckinney, Wesley Chan, Claire Durkin, Matthew Connor, Manaf Alsudaney, Brenda Durand, Nicholas N. Nissen, Hannah P. Kim, Raghavendra Paknikar, Nicole E. Rich, Matthew Schipper, Amit G. Singal. 433 THE ASSOCIATION OF SUSTAINED VIROLOGIC RESPONSE ON TREATMENT OUTCOMES IN PATIENTS WITH HEPATOCELLULAR CARCINOMA WITH HEPATITIS C. Gastroenterology 2021. PMID:


  92. Kotwani P, Chan W, Yao F, Mehta N. DCP and AFP-L3 are Complementary to AFP in Predicting High-risk Explant Features: Results of a Prospective Study. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2021. PMID: 33524592


  94. Lee BP, Im GY, Rice JP, Lazar A, Weinberg E, Han H, Maddur H, Ghobrial RM, Therapondos G, Hsu C, Fix OK, Eswaran S, Shetty K, Chhatwal J, Dalgic OO, Jakhete N, Mobley C, Victor DW, Mehta N, Dinges L, Rinella M, Schiano TD, Lucey MR, Terrault N. Patterns of Alcohol Use After Early Liver Transplantation for Alcoholic Hepatitis. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2020. PMID: 33279780


  96. Mehta N, Yao FY. Reply to HEP-20-0970. Hepatology (Baltimore, Md.) 2020. PMID: 32583439


  97. Braun HJ, Schwab MP, Jin C, Amara D, Mehta NJ, Grace TR, Croci R, Freise CE, Roberts JP, Hirose R, Ascher NL. Opioid use prior to liver transplant is associated with increased risk of death after transplant. American journal of surgery 2020. PMID: 33384155


  99. Varun Saxena, Neil Mehta. Current Transplant Criteria for Hepatocellular Carcinoma—Overuse or Underuse. Current hepatology reports 2020. PMID:


  100. Syed SM, Gardner J, Roll G, Webber A, Mehta N, Shoji J, Adelmann D, Niemann C, Braun HJ, Mello A, Yao F, Posselt A, Kang SM, Hirose R, Roberts J, Feng S, Ascher N, Stock P, Freise C. COVID-19 and Abdominal Transplant: A Stepwise Approach to Practice During Pandemic Conditions. Transplantation 2020. PMID: 32639408


  101. Rich NE, John BV, Parikh ND, Rowe I, Mehta N, Khatri G, Thomas SM, Anis M, Mendiratta-Lala M, Hernandez C, Odewole M, Sundaram LT, Konjeti VR, Shetty S, Shah T, Zhu H, Yopp AC, Hoshida Y, Yao FY, Marrero JA, Singal AG. Hepatocellular carcinoma demonstrates heterogeneous growth patterns in a multi-center cohort of patients with cirrhosis. Hepatology (Baltimore, Md.) 2020. PMID: 32017165


  102. Younis J, Freitag H, Ruthberg JS, Romanes JP, Nielsen C, Mehta N. Social Media as an Early Proxy for Social Distancing Indicated by the COVID-19 Reproduction Number: Observational Study. JMIR public health and surveillance 2020. PMID: 33001831


  103. Kwong A, Mehta N. Expanding the Limits of Liver Transplantation for Hepatocellular Carcinoma: Is There a Limit? Clinics in liver disease 2020. PMID: 33978578


  104. Lee DD, Sapisochin G, Mehta N, Gorgen A, Musto KR, Hajda H, Yao FY, Hodge DO, Carter RE, Harnois DM. Surveillance for HCC after Liver Transplantation: Increased monitoring may yield aggressive treatment options and improved postrecurrence survival. Transplantation 2020. PMID: 31972705


  105. Gorgen A, Galvin Z, Huang AC, Vinaixa C, O'Rourke JM, Francoz C, Hansen BE, Durand F, Elsharkawy AM, Shah T, Berenguer M, Rubin A, Calatayud D, Mehta N, Terrault NA, Lilly LB, Selzner N, Sapisochin G. The Impact of Direct Acting Antivirals on Overall Mortality and Tumoral Recurrence in Patients with Hepatocellular Carcinoma Listed for Liver Transplantation.: An International Multicenter Study. Transplantation 2020. PMID: 31978002


  106. Hoffman D, Mehta N. Recurrence of hepatocellular carcinoma following liver transplantation. Expert review of gastroenterology & hepatology 2020. PMID: 32933351


  107. Weinfurtner K, Dodge JL, Yao FYK, Mehta N. Effect of Nonalcoholic Fatty Liver Disease and Metabolic Risk Factors on Waitlist Outcomes in Patients With Hepatocellular Carcinoma. Transplantation direct 2020. PMID: 33134485


  108. Kim NJ, Rozenberg-Ben-Dror K, Jacob DA, Rich N, Singal AG, Aby ES, Yang JD, Nguyen V, Pillai A, Fuchs M, Moon AM, Shroff H, Agarwal PD, Perumalswami P, Chandna S, Zhou K, Patel YA, Latt NL, Wong R, Duarte-Rojo A, Lindenmeyer CC, Frenette C, Ge J, Mehta N, Yao F, Benhammou JN, Bloom PP, Leise M, Kim HS, Levy C, Barnard A, Khalili M, Ioannou GN. Provider attitudes toward risk-based hepatocellular carcinoma surveillance in patients with cirrhosis in the U.S. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2020. PMID: 32927050


  109. Zhou K, Mehta N. Downstaging to Liver Transplant: Success Involves Choosing the Right Patient. Clinics in liver disease 2020. PMID: 33012452


  110. Mehta N, Kalra A, Nowacki AS, Anjewierden S, Han Z, Bhat P, Carmona-Rubio AE, Jacob M, Procop GW, Harrington S, Milinovich A, Svensson LG, Jehi L, Young JB, Chung MK. Association of Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers With Testing Positive for Coronavirus Disease 2019 (COVID-19). JAMA cardiology 2020. PMID: 32936273


  111. Hillary Braun, Marisa P. Schwab, Chengshi Jin, Dominic Amara, Trevor Grace, Rhiannon Croci, Chris E. Freise, John P. Roberts, Neil Mehta, Ryutaro Hirose, Nancy L. Ascher. OPIOID USE PRIOR TO LIVER TRANSPLANT IS ASSOCIATED WITH INCREASED RISK OF DEATH AFTER TRANSPLANT. Transplantation 2020. PMID:


  112. Kalra A, Hawkins ES, Nowacki AS, Jain V, Milinovich A, Saef J, Thomas G, Gebreselassie SK, Karnik SS, Jehi L, Young JB, Svensson LG, Chung MK, Mehta N. Angiotensin-Converting Enzyme Inhibitors Versus Angiotensin II Receptor Blockers: A Comparison of Outcomes in Patients With COVID-19. Circulation. Cardiovascular quality and outcomes 2020. PMID: 32856462


  113. Chung MK, Karnik S, Saef J, Bergmann C, Barnard J, Lederman MM, Tilton J, Cheng F, Harding CV, Young JB, Mehta N, Cameron SJ, McCrae KR, Schmaier AH, Smith JD, Kalra A, Gebreselassie SK, Thomas G, Hawkins ES, Svensson LG. SARS-CoV-2 and ACE2: The biology and clinical data settling the ARB and ACEI controversy. EBioMedicine 2020. PMID: 32771682


  114. George Therapondos, Brian Lee, Gene Im, John Rice, Ann Lazar, Michael R. Lucey, Ethan Weinberg, Hyosun Han, Haripriya Maddur, R. Mark Ghobrial, Christine Hsu, Oren Fix, Sheila Eswaran, Kirti Shetty, Neha Jakhete, David Victor, David Foley, Neil Mehta, Mary Rinella, Thomas Schiano, Constance Mobley, Norah Terrault. THU248 Re-establishing abstinence after alcohol relapse after early transplant (LT) for alcoholic hepatitis (AH) provides survival advantage. Journal of hepatology 2020. PMID:


  115. Silverstein J, Roll G, Dodge JL, Grab JD, Yao FY, Mehta N. Donation after Circulatory Death is Associated with Similar Post-Transplant Survival in All but the Highest Risk Hepatocellular Carcinoma Patients. Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 2020. PMID: 32531867


  116. Mehta N, Parikh N, Kelley RK, Hameed B, Singal AG. Surveillance and Monitoring of Hepatocellular Carcinoma During the COVID-19 Pandemic. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2020. PMID: 32652308


  117. Jabri A, Kalra A, Kumar A, Alameh A, Adroja S, Bashir H, Nowacki AS, Shah R, Khubber S, Kanaa'N A, Hedrick DP, Sleik KM, Mehta N, Chung MK, Khot UN, Kapadia SR, Puri R, Reed GW. Incidence of Stress Cardiomyopathy During the Coronavirus Disease 2019 Pandemic. JAMA network open 2020. PMID: 32644140


  118. Mehta N, Bhangui P, Yao FY, Mazzaferro V, Toso C, Akamatsu N, Durand F, Ijzermans J, Polak W, Zheng S, Roberts JP, Sapisochin G, Hibi T, Kwan NM, Ghobrial M, Soin A. Liver Transplantation for Hepatocellular Carcinoma. Working Group Report from the ILTS Transplant Oncology Consensus Conference. Transplantation 2020. PMID: 32217938


  119. Lee E, Sarkar M, Dodge J, Kohi M, Mehta N. Shorter Height is Associated with Lower Probability of Liver Transplantation in Patients with Hepatocellular Carcinoma. Transplantation 2019. PMID: 31577670


  120. Brondfield MN, Dodge JL, Hirose R, Heimbach J, Yao FY, Mehta N. Hepatocellular carcinoma (HCC) patients listed in short wait regions remain advantaged for liver transplant (LT) following 2015 HCC policy change. Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 2019. PMID: 31833634


  121. Assalino M, Terraz S, Grat M, Lai Q, Vachharajani N, Gringeri E, Bongini MA, Kulik L, Tabrizian P, Agopian V, Mehta N, Brustia R, Vitali GC, Andres A, Berney T, Mazzaferro V, Compagnon P, Majno P, Cillo U, Chapman W, Zieniewicz K, Scatton O, Toso C. Liver transplantation for hepatocellular carcinoma after successful treatment of macrovascular invasion. Transplant international : official journal of the European Society for Organ Transplantation 2020. PMID: 31994238


  122. Mehta N. Hepatocellular Carcinoma-How to Determine Therapeutic Options. Hepatology communications 2020. PMID: 32140653


  123. Cullaro G, Rubin JB, Mehta N, Lai JC. The Differential Impact of Age Among Liver Transplant Candidates With and Without HCC. Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 2019. PMID: 31610089


  125. Mehta N, Dodge JL, Yao FY. Reply (to LTE HEP-19-0464). Hepatology (Baltimore, Md.) 2019. PMID: 31095762


  127. Acar YA, Mehta N, Rich MA, Yilmaz BK, Careskey M, Generoso J, Fidler R, Hirsch J. Using Standardized Checklists Increase the Completion Rate of Critical Actions in an Evacuation from the Operating Room: A Randomized Controlled Simulation Study. Prehospital and disaster medicine 2019. PMID: 31389323


  128. Singal AG, Rich NE, Mehta N, Branch A, Pillai A, Hoteit M, Volk M, Odewole M, Scaglione S, Guy J, Said A, Feld JJ, John BV, Frenette C, Mantry P, Rangnekar AS, Oloruntoba O, Leise M, Jou JH, Bhamidimarri KR, Kulik L, Ioannou GN, Huang A, Tran T, Samant H, Dhanasekaran R, Duarte-Rojo A, Salgia R, Eswaran S, Jalal P, Flores A, Satapathy SK, Kagan S, Gopal P, Wong R, Parikh ND, Murphy CC. Direct-Acting Antiviral Therapy for HCV Infection is Associated with Increased Survival in Patients With a History of Hepatocellular Carcinoma. Gastroenterology 2019. PMID: 31374215


  129. Rich NE, Yang JD, Perumalswami PV, Alkhouri N, Jackson W, Parikh ND, Mehta N, Salgia R, Duarte-Rojo A, Kulik L, Rakoski M, Said A, Oloruntoba O, Ioannou GN, Hoteit MA, Moon AM, Rangnekar AS, Eswaran SL, Zheng E, Jou JH, Hanje J, Pillai A, Hernaez R, Wong R, Scaglione S, Samant H, Kapuria D, Chandna S, Rosenblatt R, Ajmera V, Frenette C, Satapathy SK, Mantry P, Jalal P, John BV, Fix OK, Leise M, Lindenmeyer CC, Flores A, Patel N, Jiang ZG, Latt N, Dhanasekaran R, Odewole M, Kagan S, Marrero JA, Singal AG. Provider Attitudes and Practice Patterns for Direct-Acting Antiviral Therapy for Patients with Hepatocellular Carcinoma. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2019. PMID: 31357028


  130. Sinha J, Mehta N, Dodge JL, Poltavskiy E, Roberts J, Yao F. Are There Upper Limits in Tumor Burden for Down-staging of HCC to Liver Transplant? Analysis of the All-comers Protocol. Hepatology (Baltimore, Md.) 2019. PMID: 30779440


  131. Mehta N, Dodge JL, Hirose R, Roberts JP, Yao FY. Predictors of low risk for dropout from the liver transplant waiting list for hepatocellular carcinoma in long wait time regions: Implications for organ allocation. American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2019. PMID: 30861298


  132. Brian Lee, Mary Rinella, Gene Im, John Rice, Oren Fix, George Therapondos, Hyosun Han, David Victor, Ethan Weinberg, Cristine Hsu, Michael Voigt, Haripriya Maddur, Sheila Eswaran, David Foley, R. Mark Ghobrial, Lisanne Dinges, Jennifer Dodge, Neil Mehta, Michael R. Lucey, Norah Terrault. PS-206-Patterns and predictors of alcohol use after early liver transplant for alcoholic hepatitis. Journal of hepatology 2019. PMID:


  133. Subramanian A, Connor DM, Berger G, Lessing JN, Mehta N, Manesh R, Kohlwes J. A Curriculum for Diagnostic Reasoning: JGIM's Exercises in Clinical Reasoning. Journal of general internal medicine 2018. PMID: 30334181


  134. Mehta N, Yao FY. What Are the Optimal Liver Transplantation Criteria for Hepatocellular Carcinoma? Clinical liver disease 2019. PMID: 31168361


  135. Mehta N, Dodge JL, Roberts JP, Hirose R, Yao FY. Alpha-Fetoprotein Decrease from > 1,000 to < 500 ng/mL in Patients with Hepatocellular Carcinoma Leads to Improved Posttransplant Outcomes. Hepatology (Baltimore, Md.) 2018. PMID: 30548884


  136. Sherman CB, Behr S, Dodge JL, Roberts JP, Yao FY, Mehta N. Distinguishing Tumor from Bland Portal Vein Thrombus in Liver Transplant Candidates with Hepatocellular Carcinoma: The "A-VENA" Criteria. Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 2018. PMID: 30246323


  137. Lee DD, Samoylova M, Mehta N, Musto KR, Roberts JP, Yao FY, Harnois DM. mRECIST provides insight into tumor biology for patients with hepatocellular carcinoma awaiting liver transplantation. Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 2018. PMID: 30198150


  138. Singal AG, Rich NE, Mehta N, Branch A, Pillai A, Hoteit M, Volk M, Odewole M, Scaglione S, Guy J, Said A, Feld JJ, John BV, Frenette C, Mantry P, Rangnekar AS, Oloruntoba O, Leise M, Jou JH, Bhamidimarri KR, Kulik L, Tran T, Samant H, Dhanasekaran R, Duarte-Rojo A, Salgia R, Eswaran S, Jalal P, Flores A, Satapathy SK, Wong R, Huang A, Misra S, Schwartz M, Mitrani R, Nakka S, Noureddine W, Ho C, Konjeti VR, Dao A, Nelson K, Delarosa K, Rahim U, Mavuram M, Xie JJ, Murphy CC, Parikh ND. Direct-Acting Antiviral Therapy not Associated with Recurrence of Hepatocellular Carcinoma in a Multicenter North American Cohort Study. Gastroenterology 2019. PMID: 30660729


  140. Goldaracena N, Mehta N, Scalera I, Sposito C, Atenafu EG, Yao FY, Muiesan P, Mazzaferro V, Sapisochin G. Multicenter validation of a score to predict prognosis after the development of HCC recurrence following liver transplantation. HPB : the official journal of the International Hepato Pancreato Biliary Association 2018. PMID: 30391218


  141. Mehta N, Dodge JL, Hirose R, Roberts JP, Yao FY. Increasing Liver Transplantation Wait-List Dropout for Hepatocellular Carcinoma With Widening Geographical Disparities: Implications for Organ Allocation. Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 2018. PMID: 30067889


  142. Samoylova ML, Mehta N, Roberts JP, Yao FY. Predictors of Ultrasound Failure to Detect Hepatocellular Carcinoma. Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 2018. PMID: 29781162


  143. Roberts DE, Kakar S, Mehta N, Gill RM. A Point-based Histologic Scoring System for Hepatocellular Carcinoma Can Stratify Risk of Posttransplant Tumor Recurrence. The American journal of surgical pathology 2018. PMID: 29649017


  144. Lewin SM, Kallianos K, Nevah MI, Zhao S, Fix OK, Brooks GC, De Marco T, Qasim AN, Ordovas KG, Mehta N. Cardiac MRI T2* in Liver Transplant Candidates: Application and Performance of a Novel Imaging Technique to Identify Patients at Risk for Poor Posttransplant Cardiac Outcomes. Transplantation direct 2018. PMID: 30046653


  147. Lee BP, Mehta N, Platt L, Gurakar A, Rice JP, Lucey MR, Im GY, Therapondos G, Han H, Victor DW, Fix OK, Dinges L, Dronamraju D, Hsu C, Voigt MD, Rinella ME, Maddur H, Eswaran S, Hause J, Foley D, Ghobrial RM, Dodge JL, Li Z, Terrault NA. Outcomes of Early Liver Transplantation for Patients With Severe Alcoholic Hepatitis. Gastroenterology 2018. PMID: 29655837


  148. E. Phillips, R. Kohlbrenner, A. True-Yasaki, N. Fidelman, A. Taylor, E. Lehrman, M. Kohi, K. Kolli, R. Kerlan, N. Mehta. Abstract No. 522 Outcomes of TACE for hepatocellular carcinoma in patients with HIV infection. Journal of Vascular and Interventional Radiology 2018. PMID:


  149. M. Kohi, M. Sarka, J. Dodge, J. Roberts, N. Terrault, N. Mehta. Abstract No. 525 Liver transplantation rates for hepatocellular carcinoma: is there a sex-related difference?. Journal of Vascular and Interventional Radiology 2018. PMID:


  150. Sadler EM, Mehta N, Bhat M, Ghanekar A, Greig PD, Grant DR, Yao F, Sapisochin G. Liver Transplantation for NASH-Related Hepatocellular Carcinoma Versus Non-NASH Etiologies of Hepatocellular Carcinoma. Transplantation 2018. PMID: 29319620


  151. B. Lee, G. Im, J. Dodge, M. Voigt, J. Rice, M.R. Lucey, D. Foley, L. Platt, A. Gurakar, N. Mehta, G. Therapondos, H. Han, D. Victor, O. Fix, L. Dinges, D. Dronamraju, C. Hsu, M. Rinella, H. Maddur, S. Eswaran, J. Hause, R.M. Ghobrial, Z. Li, N. Terrault. SAT-448 Higher early post-liver transplant mortality in recipients with severe alcoholic hepatitis versus alcoholic cirrhosis. Journal of hepatology 2018. PMID:


  152. Mehta N, Yao FY. Living donor liver transplantation for hepatocellular carcinoma: To expand (beyond Milan) or downstage (to Milan)? Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 2018. PMID: 29351366


  153. Azeem N, Ajmera V, Hameed B, Mehta N. Hilar cholangiocarcinoma associated with immunoglobulin G4-positive plasma cells and elevated serum immunoglobulin G4 levels. Hepatology communications 2018. PMID: 29619414


  154. Mehta NJ, Latoures R, Stechert MM, Fidler RL, Hirsch J. Interventions to improve the mechanical ventilation fidelity of the Laerdal SimMan® 3G simulation mannequin. Canadian journal of anaesthesia = Journal canadien d'anesthesie 2017. PMID: 29243162


  155. Mehta N, Dodge JL, Roberts JP, Yao FY. Validation of the prognostic power of the RETREAT score for hepatocellular carcinoma recurrence using the UNOS database. American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2017. PMID: 29068145


  156. Mehta N, Yao FY. Con: Treating hepatitis C virus With direct-acting antivirals: Fear not the perceived threat of hepatocellular carcinoma. Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 2017. PMID: 29024442


  157. Mehta N, Elo I, Stenholm S, Aromaa A, Heliövaara M, Koskinen S. International Differences in the Risk of Death from Smoking and Obesity: The Case of the United States and Finland. . 2017. PMID: 28798949


  158. Mehta N, Guy J, Frenette CT, Dodge JL, Osorio RW, Minteer WB, Roberts JP, Yao FY. Excellent Outcomes of Liver Transplantation Following Down-Staging of Hepatocellular Carcinoma to Within Milan Criteria: A Multicenter Study. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2017. PMID: 29175528


  160. Mehta N, Heimbach J, Lee D, Dodge JL, Harnois D, Burns J, Sanchez W, Roberts JP, Yao FY. Wait Time of Less Than 6 and Greater Than 18 Months Predicts Hepatocellular Carcinoma Recurrence After Liver Transplantation: Proposing a Wait Time "Sweet Spot". Transplantation 2017. PMID: 28353492


  161. Lewin SM, Mehta N, Kelley RK, Roberts JP, Yao FY, Brandman D. Liver transplantation recipients with nonalcoholic steatohepatitis have lower risk hepatocellular carcinoma. Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 2017. PMID: 28340509


  162. Sabatino JJ, Mehta NJ, Kakar S, Zamvil SS, Cree BAC. Acute liver injury in a Glatopa-treated patient with MS. Neurology(R) neuroimmunology & neuroinflammation 2017. PMID: 28626784


  164. Mehta N, Heimbach J, Harnois DM, Sapisochin G, Dodge JL, Lee D, Burns JM, Sanchez W, Greig PD, Grant DR, Roberts JP, Yao FY. Validation of a Risk Estimation of Tumor Recurrence After Transplant (RETREAT) Score for Hepatocellular Carcinoma Recurrence After Liver Transplant. JAMA oncology 2017. PMID: 27838698


  165. Mehta NJ, Celik AD, Peters MG. Screening for hepatocellular carcinoma: What is missing? Volume 1 of Issue 1. 2016. PMID: 29404430


  166. Mehta N, Yao FY. Transarterial Radioembolization for Hepatocellular Carcinoma: Who, When… and Y(90)? Gastroenterology 2016. PMID: 27983951


  167. Sapisochin G, Facciuto M, Rubbia-Brandt L, Marti J, Mehta N, Yao FY, Vibert E, Cherqui D, Grant DR, Hernandez-Alejandro R, Dale CH, Cucchetti A, Pinna A, Hwang S, Lee SG, Agopian VG, Busuttil RW, Rizvi S, Heimbach JK, Montenovo M, Reyes J, Cesaretti M, Soubrane O, Reichman T, Seal J, Kim PT, Klintmalm G, Sposito C, Mazzaferro V, Dutkowski P, Clavien PA, Toso C, Majno P, Kneteman N, Saunders C, Bruix J. Liver transplantation for "very early" intrahepatic cholangiocarcinoma: International retrospective study supporting a prospective assessment. Hepatology (Baltimore, Md.) 2016. PMID: 27481548


  168. Mehta N, Yao FY. Reply. Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 2016. PMID: 27097078


  169. Sarkar M, Dodge JL, Roberts JP, Terrault N, Yao F, Mehta N. Increased hepatocellular carcinoma recurrence in women compared to men with high alpha fetoprotein at liver transplant. Annals of hepatology 2016. PMID: 27236153


  170. Mehta N, Roberts JP, Yao FY. Lack of benefits of mammalian target of rapamycin inhibitor in patients transplanted for hepatocellular carcinoma: Is this the end of the story? Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 2016. PMID: 26951991


  171. Lê-Scherban F, Albrecht SS, Bertoni A, Kandula N, Mehta N, Diez Roux AV. Immigrant status and cardiovascular risk over time: results from the Multi-Ethnic Study of Atherosclerosis. Annals of epidemiology 2016. PMID: 27221804


  172. G. Sapisochin, N. Mehta, I. Scalera, C. Sposito, F.Y. Yao, P. Muiesan, V. Mazzaferro, D.R. Grant. HCC recurrence following liver tranplantation should be aggresively treated to increase patient survival. Hepato Pancreato Biliary 2016. PMID:


  173. Mehta N, Yao FY. Hepatocellular cancer as indication for liver transplantation: pushing beyond Milan. Current opinion in organ transplantation 2016. PMID: 26807513


  174. G. Sapisochin, M. Facciuto, N. Mehta, E. Vibert, R. Hernandez-Alejandro, A.D. Pinna, S. Hwang, V.G. Agopian, G. Gores, J. Reyes, O. Soubrane, T. Reichman, P. Kim, C. Sposito, P.A. Clavien, C. Toso, N. Kneteman, J. Bruix. “Very early” intrahepatic cholangiocarcinoma may become an acceptable indication for liver transplantation. A multicenter validation study. Hepato Pancreato Biliary 2016. PMID:


  176. Mehta N, Sarkar M, Dodge JL, Fidelman N, Roberts JP, Yao FY. Intention to treat outcome of T1 hepatocellular carcinoma with the "wait and not ablate" approach until meeting T2 criteria for liver transplant listing. Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 2016. PMID: 26479422


  177. Mehta N, Heimbach J, Hirose R, Roberts JP, Yao FY. Minimal Transplant Survival Benefit for Hepatocellular Carcinoma: Is it Real or an Overestimation of Waitlist Life Expectancy? Gastroenterology 2015. PMID: 26718172


  178. Gabriel Brooks, Kathryn Brown, Neil Mehta, Karen Ordovas, Nevah Rubin, Elyse Foster, Atif Qasim. Abstract 19009: The Association Between Clinical and Echocardiographic Imaging Findings and T2* in End Stage Liver Disease. Circulation 2015. PMID:


  179. Yao FY, Mehta N, Flemming J, Dodge J, Hameed B, Fix O, Hirose R, Fidelman N, Kerlan RK, Roberts JP. Downstaging of hepatocellular cancer before liver transplant: long-term outcome compared to tumors within Milan criteria. Hepatology (Baltimore, Md.) 2015. PMID: 25689978


  180. Samoylova ML, Dodge JL, Mehta N, Yao FY, Roberts JP. Evaluating the validity of model for end-stage liver disease exception points for hepatocellular carcinoma patients with multiple nodules <2 cm. Clinical transplantation 2014. PMID: 25366656


  181. Goel A, Mehta N, Guy J, Fidelman N, Yao F, Roberts J, Terrault N. Hepatic artery and biliary complications in liver transplant recipients undergoing pretransplant transarterial chemoembolization. Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 2014. PMID: 25045002


  182. Yao FY, Hameed B, Mehta N, Roberts JP. Response to letter to the editors. Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 2014. PMID: 25155484


  183. Hameed B, Mehta N, Sapisochin G, Roberts JP, Yao FY. Alpha-fetoprotein level > 1000 ng/mL as an exclusion criterion for liver transplantation in patients with hepatocellular carcinoma meeting the Milan criteria. Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 2014. PMID: 24797281


  184. M. Samoylova, J. Dodge, F. Yao, N. Mehta, J. Roberts. Should Hepatocellular Carcinoma Patients With Multiple Tumors <2cm Be Transplanted?. Transplantation Journal 2014. PMID:


  185. Mehta N, Dodge JL, Roberts JP, Hirose R, Yao FY. Outcomes after liver transplantation for patients with hepatocellular carcinoma and a low risk of dropout from the transplant waiting list. Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 2014. PMID: 24493311


  186. Srinivasan M, Mehta N. BMJ endgames: a new web-based BMJ/JGIM collaboration. Journal of general internal medicine 2014. PMID: 24395105


  187. Mehta N, Dodge JL, Goel A, Roberts JP, Hirose R, Yao FY. Identification of liver transplant candidates with hepatocellular carcinoma and a very low dropout risk: implications for the current organ allocation policy. Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 2013. PMID: 24285611


  188. Mendelsohn BA, Mehta N, Hameed B, Pekmezci M, Packman S, Ralph J. Adult-Onset Fatal Neurohepatopathy in a Woman Caused by MPV17 Mutation. JIMD reports 2013. PMID: 24190800


  189. Mehta N, Yao FY. Moving past "One size (and number) fits all" in the selection of candidates with hepatocellular carcinoma for liver transplantation. Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 2013. PMID: 23959652


  190. Yao F, Mehta N. Reply: To PMID 23333661. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2013. PMID: 24035772


  191. Mehta N, Hirose R. Immunosuppression: Conventions and controversies. Clinical liver disease 2013. PMID: 30992859


  192. Mehta N, Fidelman N, Sarkar M, Yao FY. Factors associated with outcomes and response to therapy in patients with infiltrative hepatocellular carcinoma. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2013. PMID: 23333661


  193. Neil Mehta, Aparna Goel, Karen C. Bagatelos, James L. Buxbaum, Nicholas Fidelman, John P. Roberts, Norah A. Terrault, Francis Yao, James W. Ostroff. 1016 Risk of Hepatic Artery and Biliary Complications in Liver Transplant Recipients Treated With Transarterial Chemoembolization. Gastroenterology 2012. PMID:


  194. Miller J, Mehta N, Feldman M, Furth E, Ginsberg GG, Yang YX, Lewis JD. Findings on serial surveillance colonoscopy in patients with low-risk polyps on initial colonoscopy. . 2010. PMID: 19620883


  195. Mehta N, Mauer AM, Hellman S, Haraf DJ, Cohen EE, Vokes EE, Weichselbaum RR. Analysis of further disease progression in metastatic non-small cell lung cancer: implications for locoregional treatment. International journal of oncology 2004. PMID: 15547705


  196. Salama JK, Roeske JC, Mehta N, Mundt AJ. Intensity-modulated radiation therapy in gynecologic malignancies. Current treatment options in oncology 2004. PMID: 14990204